Summary
Latest filing:
Barry H. Dash is Director of ELITE PHARMACEUTICALS INC /NV/ (ELTP). 1 SEC Form 4 filing on record, dated 10 September 2026. Most recent open-market trade: bought $9K of ELTP on 10 September 2026. Lifetime open-market purchases: $9K.
Recent Transactions
1Every recent SEC Form 4 transaction Barry H. Dash has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Barry H. Dash files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Douglas Plassche - $499K of ELTP open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Barry H. Dash?
Barry H. Dash is a corporate insider, tracked as Director of ELITE PHARMACEUTICALS INC /NV/ (ELTP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Barry H. Dash submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Barry H. Dash been buying or selling stock?
Recorded transactions: 1 open-market purchase ($9K) and 0 open-market sales across all tracked filings.
Where can I see all of Barry H. Dash's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Barry H. Dash and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
